ALFA Finder India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold Telegram alerts alfafinder.com →

Thursday, 12 November 2026 Every NSE & BSE announcement, by company

ALFA Filings Every announcement, straight from the exchange

Jubilant Pharmova Ltd

NSE: JUBLPHARMA · BSE: 530019 · Pharmaceuticals & Biotechnology · 40 announcements

Share price: ₹987.50
Market cap: ₹15,729 Cr
Revenue (annual): ₹8,280 Cr
Net profit (annual): ₹398.5 Cr
P/E (TTM): 44.7×Sector 43.8×
Promoter holding: 47.68%+0.00% QoQ
FII holding: 15.37%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Debt & Borrowing 1 Business Update 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

5 Nov 2026 22:22 IST BSE

Debt & Borrowing

Jubilant Pharmova Debt & Borrowing: ₹800 Cr

Jubilant Pharmova allotted 80,000 unsecured NCDs worth Rs 800 Crore on a private placement basis. The 8.50% debentures mature in November 2028.

Value: ₹800.0 Cr
Execution: 3 years (maturity 05 November 2028)

Open announcement → Read the filing ↗

Jubilant Pharmova Ltd by type